356 related articles for article (PubMed ID: 28119967)
1. A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy.
Zeng L; Kuang S; Li G; Jin C; Ji L; Chao H
Chem Commun (Camb); 2017 Feb; 53(12):1977-1980. PubMed ID: 28119967
[TBL] [Abstract][Full Text] [Related]
2. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
Zhao X; Li M; Sun W; Fan J; Du J; Peng X
Chem Commun (Camb); 2018 Jun; 54(51):7038-7041. PubMed ID: 29873358
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
4. Intracellular GSH-activated galactoside photosensitizers for targeted photodynamic therapy and chemotherapy.
Wang C; Liu L; Cao H; Zhang W
Biomater Sci; 2017 Jan; 5(2):274-284. PubMed ID: 27942618
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of efficient heavy-atom-free photosensitizers for photodynamic therapy of cancer.
Nguyen VN; Park SJ; Qi S; Ha J; Heo S; Yim Y; Baek G; Lim CS; Lee DJ; Kim HM; Yoon J
Chem Commun (Camb); 2020 Sep; 56(77):11489-11492. PubMed ID: 32857074
[TBL] [Abstract][Full Text] [Related]
6. A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy.
Cao JJ; Zhang MS; Li XQ; Yang DC; Xu G; Liu JY
Eur J Med Chem; 2020 May; 193():112203. PubMed ID: 32197150
[TBL] [Abstract][Full Text] [Related]
7. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
8. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611
[TBL] [Abstract][Full Text] [Related]
9. Novel ruthenium azo-quinoline complexes with enhanced photonuclease activity in human cancer cells.
Kaulage MH; Maji B; Pasadi S; Bhattacharya S; Muniyappa K
Eur J Med Chem; 2017 Oct; 139():1016-1029. PubMed ID: 28910739
[TBL] [Abstract][Full Text] [Related]
10. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
[TBL] [Abstract][Full Text] [Related]
11. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus.
Zhao F; Wang W; Wu W
Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
13. The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers.
Qiu K; Wen Y; Ouyang C; Liao X; Liu C; Rees TW; Zhang Q; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(75):11235-11238. PubMed ID: 31469153
[TBL] [Abstract][Full Text] [Related]
14. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
15. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
16. A folate-conjugated platinum porphyrin complex as a new cancer-targeting photosensitizer for photodynamic therapy.
Yang M; Deng J; Guo D; Zhang J; Yang L; Wu F
Org Biomol Chem; 2019 May; 17(21):5367-5374. PubMed ID: 31106316
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
18. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
19. Taurine-modified Ru(ii)-complex targets cancerous brain cells for photodynamic therapy.
Du E; Hu X; Roy S; Wang P; Deasy K; Mochizuki T; Zhang Y
Chem Commun (Camb); 2017 May; 53(44):6033-6036. PubMed ID: 28524186
[TBL] [Abstract][Full Text] [Related]
20. Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy.
Huang H; Yu B; Zhang P; Huang J; Chen Y; Gasser G; Ji L; Chao H
Angew Chem Int Ed Engl; 2015 Nov; 54(47):14049-52. PubMed ID: 26447888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
